Drug Database
Back to search

Belgium· BE-AMP-SAM534746-00

Mepsevii 2 mg/ml

A vestronidase alfa product containing vestronidase alfa, registered in Belgium by Ultragenyx Germany. The same ATC class is registered in 10 of our 19 countries.

ATC A16AB18

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedMepsevii 2 mg/mlATCA16AB18REGISTER NO.BE-AMP-SAM534746-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about vestronidase alfaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Vestronidase alfa is registered in 10 of 19 countries.

Countries holding a registration under ATC A16AB18 (vestronidase alfa), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose
Search vestronidase alfa products by name

Vestronidase alfa · ATC A16AB18

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Vestronidase Alfa
Manufacturer
Ultragenyx Germany
Country
Belgium (BE)
ATC code
A16AB18
ATC class
Vestronidase alfa
Defined daily dose
20 mg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Vestronidase alfa in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vestronidase alfa products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Mepsevii
  • Liechtenstein · Mepsevii
  • Norway · Mepsevii

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8025beab-a128-4436-9885-343a028f55a4
GET /v1/drugs/8025beab-a128-4436-9885-343a028f55a4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentrate for solution for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Mepsevii 2 mg/ml",
  "name_fr": "Mepsevii 2 mg/ml",
  "name_nl": "Mepsevii 2 mg/ml",
  "amp_code": "SAM534746-00",
  "strengths": [
    "2.0000",
    "17.8000"
  ],
  "pack_count": 1,
  "substances": [
    "Vestronidase Alfa",
    "Polysorbate 20",
    "Sodium"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Vestronidase Alfa",
  "authorisation_numbers": [
    "EU/1/18/1301/001"
  ]
}
API referenceMCP serverPlans

See everything about vestronidase alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console